Arthritis Drug Returns to TV, While New Study Shows High Risk Cardiac Patients with Osteoarthritis Taking Ibuprofen Have Nine-Fold Increased Heart Attack Risk
While Pfizer Inc. returns to a TV media campaign for Celebrex for the first time since December 2004 last night, a team of researchers at Mount Sinai School of Medicine released a new study showing Ibuprofen puts high risk cardiac patients with osteoarthritis at risk for heart attack nine-fold due to drug interaction. It's no wonder, according to a new study, more than 100 million people are searching the Internet for dietary supplements as an alternative.
Boca Raton, FL (PRWEB) May 3, 2007 -- After lengthy hiatus Pfizer is running their Celebrex arthritis drug on TV again after pulling their ads due to the controversy surrounding Merck & Co.'s Vioxx. But instead of launching into the benefits of Celebrex, the narrator of the ad initially explains the risk - including the word "death." In addition, in the first study of its kind, a team of researchers at Mount Sinai School of Medicine recently have shown Ibuprofen puts high risk cardiac patients with osteoarthritis at risk for heart attack nine-fold due to drug interaction. It's no wonder, according to a study from Bayer HealthCare - one of the largest marketers of over-the-counter dietary supplements in the world - that more than 100 million people have searched the Internet for information on dietary and nutritional supplements. What is the consumer to do once their drug has been pulled off the market or they can't take a simple aspirin or Ibuprofen for joint discomfort?
"Millions of Americans with joint discomfort and arthritis are desperately seeking a natural alternative to harsh pharmaceuticals and anything that can cause drug interaction," said Ria Romano, PR Manager, LaKOTA-USA. "It has become an issue of trust for the consumer. They are looking for tried and true arthritis dietary supplements and topical solutions they can trust. The LaKOTA brand of products have been leading the way in Canada since 2003 and are trusted by million of Canadians to alleviate their joint discomfort. Americans can look to Canada with great confidence for what works. Best of all, LaKOTA products are conveniently available immediately for U.S. consumers at mass retailers, Walgreens stores, Walgreens.com, CVS.com, and Costco.com," concluded Romano.
LaKOTA Maximum Strength Joint Care Formula provides 1500 mg per serving of Glucosamine HCL with a proprietary blend of boswellia extract, collagen type II, white willow bark, yucca root, devil's claw root, sarsaparilla root, feverfew leaf, and bromelain. Taken orally twice daily it helps facilitate the renewal and lubrication of cartilage for both men and women, while promoting joint comfort, range of motion and flexibility. Also available immediately in the U.S. nationwide is the LaKOTA Topical Pain Relieving Gel - Arthritis Formula - which has been Canada's #1 selling topical pain reliever for arthritis according to ACNielsen 2006, Drug. The topical roll-on provides penetrating pain relief for minor aches and pains of muscles and joints associated with arthritis, simple backache, strains and sprains.
"LaKOTA products are based on the knowledge of traditional Native American formulas," Romano continued. "Recent years have shown a surge of interest in the therapies of traditional cultures. Some hospitals have even included traditional Native American healers as part of their staff. Numerous studies demonstrate that a Native American inspired treatment approach can be beneficial for consumers of non-Native cultural backgrounds with positive effects."
LaKOTA Joint Care Formula Maximum Strength with is available at mass retailers nationwide, Walgreens stores, Walgreens.com, CVS.com and Costco.com. In LaKOTA Topical Pain Relieving Roll-on - Arthritis Formula - is now available to consumers nationwide at Costco.com in a special Twin Pak, at Walgreens.com and in the future at CVS.com. For more information, visit www.lakota-usa.com.
###
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1TdW1tLUhhbGYtQ3Jhcy1NYWduLVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.